STAAR Surgical's (NASDAQ:STAA) Earnings Have Declined Over Three Years, Contributing to Shareholders 71% Loss
STAAR Surgical's (NASDAQ:STAA) Earnings Have Declined Over Three Years, Contributing to Shareholders 71% Loss
As every investor would know, not every swing hits the sweet spot. But you have a problem if you face massive losses more than once in a while. So take a moment to sympathize with the long term shareholders of STAAR Surgical Company (NASDAQ:STAA), who have seen the share price tank a massive 71% over a three year period. That'd be enough to cause even the strongest minds some disquiet. Shareholders have had an even rougher run lately, with the share price down 12% in the last 90 days.
正如每位投資者所知,不是每次波動都能達到理想點。但如果您偶爾面臨巨額虧損,那就有問題了。因此,請花點時間同情一下納斯達克公司(納斯達克:STAA)的長期股東,他們在過去三年中見證了股價暴跌71%。這足以讓即使是最堅強的頭腦也感到不安。股東們最近的情況更糟,股價在過去90天下跌了12%。
While the stock has risen 7.3% in the past week but long term shareholders are still in the red, let's see what the fundamentals can tell us.
儘管股價在過去一週上漲了7.3%,但長期股東仍處於虧損狀態,讓我們看看基本面能告訴我們什麼。
To quote Buffett, 'Ships will sail around the world but the Flat Earth Society will flourish. There will continue to be wide discrepancies between price and value in the marketplace...' One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.
引用巴菲特的話:「船隻將周遊世界,而『地平派』仍會興旺。市場上的價格和價值仍會存在廣泛的差距……」考慮一家公司在市場上的認知如何變化的一個不完美但簡單的方法是比較每股收益(EPS)的變化和股價的波動。
STAAR Surgical saw its EPS decline at a compound rate of 3.3% per year, over the last three years. The share price decline of 33% is actually steeper than the EPS slippage. So it's likely that the EPS decline has disappointed the market, leaving investors hesitant to buy. Having said that, the market is still optimistic, given the P/E ratio of 63.48.
在過去三年中,STAAR Surgical的每股收益以年複合率3.3%的速度下降。股價下跌33%,實際上比每股收益的滑坡更爲陡峭。因此,每股收益下降可能讓市場感到失望,使投資者猶豫不前。話雖如此,鑑於市盈率爲63.48,市場仍然持樂觀態度。
The graphic below depicts how EPS has changed over time (unveil the exact values by clicking on the image).
下圖顯示了EPS隨時間變化的情況(點擊圖像以顯示確切值)。
We like that insiders have been buying shares in the last twelve months. Even so, future earnings will be far more important to whether current shareholders make money. Before buying or selling a stock, we always recommend a close examination of historic growth trends, available here..
我們喜歡內部人士在過去12個月裏購買股票。即便如此,未來的盈利將更加重要,這將決定當前股東是否能賺錢。在買賣股票之前,我們總是建議仔細審查歷史增長趨勢,在這裏可以獲得相關信息。
A Different Perspective
另一種看法
While the broader market gained around 35% in the last year, STAAR Surgical shareholders lost 12%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Unfortunately, last year's performance may indicate unresolved challenges, given that it was worse than the annualised loss of 4% over the last half decade. We realise that Baron Rothschild has said investors should "buy when there is blood on the streets", but we caution that investors should first be sure they are buying a high quality business. Investors who like to make money usually check up on insider purchases, such as the price paid, and total amount bought. You can find out about the insider purchases of STAAR Surgical by clicking this link.
儘管整體市場在過去一年中上漲了約35%,但STAAR Surgical的股東們卻損失了12%。然而,請記住,即使是最好的股票有時也會在12個月的時間內表現不佳。不幸的是,去年的表現可能表明存在未解決的挑戰,因爲它比過去半個世紀年化的4%的損失還要糟糕。我們意識到,巴倫·羅斯柴爾德曾說過投資者應該"在街上有流血時買入",但我們提醒投資者首先要確保他們正在購買的是一家高質量的企業。通常喜歡賺錢的投資者會查看內部人士的購買情況,比如價格和購買總額。您可以通過點擊此鏈接了解STAAR Surgical的內部人員購買情況。
STAAR Surgical is not the only stock that insiders are buying. For those who like to find lesser know companies this free list of growing companies with recent insider purchasing, could be just the ticket.
STAAR Surgical並不是唯一一家內部人員在購買的股票。對於那些喜歡發現較不爲人知的公司的人來說,擁有最近內部人員購買股票的增長公司的免費名單可能正合適。
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.
請注意,本文所引述的市場回報反映了目前在美國交易所上市的股票的市場加權平均回報。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接與我們聯繫。或者,發送電子郵件至editorial-team @ simplywallst.com。
Simply Wall St的這篇文章是一般性質的。我們僅基於歷史數據和分析師預測提供評論,使用公正的方法,我們的文章並非意在提供財務建議。這並不構成買入或賣出任何股票的建議,並且不考慮您的目標或財務狀況。我們旨在爲您帶來基於基礎數據驅動的長期聚焦分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St對提及的任何股票都沒有持倉。
譯文內容由第三人軟體翻譯。